Sernova (TSE:SVA) Shares Down 5.8%

Sernova Corp. (TSE:SVA)’s share price was down 5.8% during trading on Thursday . The company traded as low as C$0.40 and last traded at C$0.41. Approximately 21,300 shares were traded during trading, a decline of 85% from the average daily volume of 145,764 shares. The stock had previously closed at C$0.43.

Analyst Ratings Changes

Separately, Raymond James set a C$1.50 price objective on Sernova and gave the stock a “market perform” rating in a research note on Thursday, April 4th.

Sernova Stock Down 2.4 %

The company’s 50-day simple moving average is C$0.52 and its 200 day simple moving average is C$0.62. The company has a debt-to-equity ratio of 16.55, a current ratio of 1.20 and a quick ratio of 18.11. The firm has a market cap of C$121.36 million, a P/E ratio of -3.08 and a beta of 1.60.

Sernova (TSE:SVA) last released its quarterly earnings results on Monday, March 18th. The company reported C($0.03) EPS for the quarter, hitting the consensus estimate of C($0.03). Research analysts anticipate that Sernova Corp. will post -0.08 EPS for the current fiscal year.

About Sernova

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.